It is a pharma public limited company based in Roorkee, Uttarakhand, India, established in 2005.
2005 | Roorkee, Uttarakhand, India | ActiveI G Pharma Limited, a active public limited company, was established on 14 June 2005 in Roorkee, Uttarakhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232UR2005PLC011213. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.83 M.
It upholds a compliant status. Employing 24 professional, Its leadership includes Krishana Devi (Director), Ashok Kumar (Director), Vikram Chugh (Director). Past directors included Sandeep Khandelwal, Vyapak Krishan Puri, Krishana Devi. It holds ₹7.26 Cr open charges and ₹16.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12.4 Km Meerut Road Roorkee Libberheri, Roorkee, Uttarakhand, 247667.
U24232UR2005PLC011213
011213
14 June 2005
₹5.00 M
₹4.83 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into I G Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishana Devi | Director | 03 Sep 2021 | Current |
| Ashok Kumar | Director | 12 Jun 2024 | Current |
| Vikram Chugh | Director | 03 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Jun 2013 | Past |
| Pramod Abcsdd | Director | 05 Aug 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 08 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 15 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
I G Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.19% increase. The company also saw a substantial fall in profitability, with a 16.18% decrease in profit. The company's net worth moved up by a moderate rise of 3.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, I G Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹72,630,000.00
₹166,008,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2024 | Hdfc Bank Limited | ₹5.99 Cr | Open |
| 11 Sep 2023 | Sidbi | ₹1.00 Cr | Open |
| 26 Jun 2020 | Others | ₹0.65 M | Open |
| 23 Jun 2020 | Others | ₹0.68 M | Open |
| 15 Oct 2016 | Dena Bank | ₹1.40 M | Open |
Explore comprehensive loan charge details -
I G Pharma has a workforce of 24 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of I G Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I G Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited of Rs. 59.90 M registered on 10 Jul 2024 with Charge ID 100954506 was modified on 24 Apr 2025. was documented.
The activity I G Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge registered on 09 Mar 2022 via Charge ID 100555101 with Axis Bank Limited was fully satisfied on 02 Sep 2024. was recorded as a recent event.
The activity A charge registered on 09 Mar 2022 via Charge ID 100549662 with Axis Bank Limited was fully satisfied on 02 Sep 2024. was completed.
Progress on A charge registered on 09 Mar 2022 via Charge ID 100549654 with Axis Bank Limited was fully satisfied on 02 Sep 2024. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 59.90 M with Charge ID 100954506 was registered on 10 Jul 2024. was completed.
The CIN of I G Pharma Limited is U24232UR2005PLC011213.
I G Pharma Limited is headquartered at 12.4 Km Meerut Road Roorkee Libberheri, Roorkee, Uttarakhand, 247667.
I G Pharma Limited was incorporated on 14 June 2005.
The current directors of I G Pharma Limited are
The primary industry of I G Pharma Limited is Manufacturing.
I G Pharma Limited is unlisted.
The authorized capital of I G Pharma Limited is ₹5.00 M, and the paid-up capital is ₹4.83 M.
The compliance status of I G Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX